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Abstract 
Even though the borderline concept has historically been intertwined with psychosis, psychotic symptoms 
in people with borderline personality disorder (BPD) have long been marginalized as somehow not real, 
transient, or “pseudo” in nature. Dispelling this myth, we summarize recent research indicating that (a) 
psychotic symptoms in general and auditory verbal hallucinations in particular in people with BPD show 
more similarities than differences with those symptoms in people with psychotic disorders, and (b) that the 
co-occurrence of BPD and psychotic symptoms is a marker of severe psychopathology and of risk for 
poor outcome (e.g., suicidality). We propose the period from puberty to the mid-20s, when both BPD and 
psychotic features usually emerge for the first time, constitutes a critical time window for early 
intervention to prevent the development of severe mental disorders in the future. Implications for the 
treatment of psychotic symptoms in BPD and future research directions in this field are discussed.  
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1. The role of psychotic symptoms in the development of the borderline personality disorder 
concept and classification 
Historically, the term “borderline state” or “borderline patient” described a clinical presentation that had 
both a psychotic and neurotic appearance [1]. For a long time, substantial conceptual confusion existed, 
with some viewing “borderline” as either a form of schizophrenia (e.g., latent, pseudoneurotic or 
borderline schizophrenia) or a disorder of personality structure (i.e., Kernberg’s borderline personality 
organization) [2]. With the introduction of the third revision of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-III) [3], the borderline personality disorder (BPD) diagnosis officially entered the 
psychiatric classification system. Here, it was separated from schizotypal personality disorder (SPD), 
which was thought to belong to the schizophrenia spectrum [2], and psychotic symptoms were, despite 
considerable controversy, omitted from the BPD criteria list [4]. It was not until the fourth revision of the 
DSM that psychotic symptoms in the form of “transient, stress-related paranoid ideation or severe 
dissociative symptoms” were added as an additional criterion to the BPD diagnosis [5]. The DSM BPD 
criteria have remained unchanged in section II of the current fifth revision [6]. In the alternative model of 
personality disorders in section III of the DSM-5, psychotic symptoms are not listed as a central feature of 
BPD, but the trait “psychoticism” (i.e., cognitive and perceptual dysregulation) can be specified when 
appropriate [6].  
 The BPD diagnosis only entered the International Classification of Diseases and Related Health 
Problems in 1992 in the 10th edition (ICD-10) [7] as the borderline subtype of emotionally unstable 
personality disorder and has never included psychotic experiences. The forthcoming eleventh edition of 
the ICD will adopt a dimensional rating of personality dysfunction, with a borderline pattern descriptor 
applied when relevant, which reads in part “…transient dissociative symptoms or psychotic-like features 
in situations of high affective arousal.” [8].   
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The last two decades has seen an increasing number of studies of psychotic symptoms in BPD that 
have used larger samples than earlier, with more appropriate comparison groups, and standardized tools to 
assess psychotic symptoms. In this review, we will summarize this new research to evaluate the validity of 
the long-standing notion that psychotic symptoms in BPD are stress-dependent, transient, limited to 
paranoia, and “atypical” or “quasi-psychotic” (i.e., circumscribed, short-lived, and non-bizarre) [9] or 
even “factitious” [10]. Complementing recent reviews on this topic [e.g., 11–15], we will include both 
studies of adults and youth (i.e., adolescents and young adults) samples. In addition, we will propose a 
developmental framework for the co-occurrence of BPD and psychotic symptoms in youth, discuss 
implications for treatment, and identify key questions for future research. 
 
2.  What we know about psychotic symptoms in borderline personality disorder  
2.1.  Psychotic symptoms in BPD are manifold and phenomenologically similar to those in schizophrenia 
spectrum disorders 
Auditory verbal hallucinations (AVH) are the most common form of psychotic symptoms among patients 
with BPD [16–18]. Studies in adult samples have demonstrated that 29%-50% of patients report AVH 
[13,16,19]. These symptoms occur frequently and are perceived as critical, controlling, distressing, 
malevolent, omnipotent, and of higher social power than the person with BPD [17,19–21]. Studies 
comparing psychotic symptoms in groups of patients with schizophrenia or with BPD have reported no 
group differences in most characteristics of AVH, including frequency, duration, location (i.e., inside or 
outside the head), loudness, or conviction [16,18,22]. However, patients with BPD have reported their 
voices to be more distressing, more negative in content [16] and less disruptive to life [22]. Moreover, 
they felt more controlled by their voices [18] and had greater emotional resistance to them [23]. No group 
differences have been found in the prevalence of commenting voices, whereas dialoguing voices have 
been found to be significantly more present in patients with schizophrenia (71%), compared with patients 
with BPD (40%) [18]. AVH in patients with BPD have been found to emerge at a younger age (during 
adolescence) than in patients with schizophrenia (during early adulthood) [18,22].  
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 Adult patients with BPD experience a wide range of other psychotic symptoms in addition to 
AVH, including hallucinations (11% visual hallucinations, 8% gustatory hallucinations, 17% olfactory 
hallucinations, 15% tactile hallucinations [19]), thought insertion (100%), thought blocking (90%), being 
influenced by another agent (70%) [21], dissociation (17-90%) [17,21], delusions (20%) [17], and ideas of 
reference (27%) [17]. Compared with patients with schizophrenia, patients with BPD report less 
delusions, conceptual disorganization and negative symptoms [e.g., blunted affect or social withdrawal; 
,16,18]. Hallucinations in patients with BPD are associated with delusions, but not negative symptoms or 
disorganization [19].    
Only a few studies have investigated the influence of stress on psychotic symptoms in BPD. 
Niemantsverdriet et al. [19] reported a positive correlation between the severity of hallucinations and the 
number of current life stressors. Using experience sampling technique, Glaser and colleagues [24] found 
patients with BPD experienced the strongest psychotic reactivity to daily life stress compared with 
patients with a psychotic disorder or a cluster C personality disorder and healthy controls, and that 
psychotic reactivity in BPD was not limited to paranoia, but involved a broader range of psychotic 
experiences, including hallucinations. 
While most studies examined adult samples, AVH and other psychotic symptoms have recently 
been explored in outpatient youth (15 to 25-year olds) with either a first manifestation of BPD or 
schizophrenia spectrum disorder. These results confirmed those from the adult literature. AVH 
experienced by youth with BPD were indistinguishable from AVH occurring in youth with schizophrenia 
spectrum disorder with regard to physical (frequency, duration, location and loudness), cognitive (beliefs 
regarding origin of voices, disruption to life and controllability), and emotional characteristics (negative 
content and distress) [25]. However, youth with BPD + AVH had less severe delusions and difficulties in 
abstract thinking compared with those with schizophrenia spectrum + AVH [25]. Interestingly, youth with 
BPD held more negative beliefs about their voices in terms of supremacy of voices than those with 
schizophrenia spectrum disorder and these beliefs were closely linked to depression [26]. 
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2.2.  Psychotic symptoms in BPD are an indicator of illness severity and poor outcome 
Studies in adults with BPD have found that AVH are associated with a higher number of BPD criteria, 
more co-occurring mental disorders [19], more symptoms of depression and anxiety, feelings of loneliness 
and schizotypy [27], and a higher incidence of suicidal plans and attempts in the month prior to study and 
a higher number of hospital admissions over two years after baseline [28]. Both visual and auditory 
hallucinations in patients with BPD are associated with a 2.23-fold increase in suicide attempts [29], and 
both hallucinations and delusions in patients with BPD are significant predictors of a quicker readmission 
to acute psychiatric inpatient care after discharge [30]. Finally, co-occurring psychotic disorder in patients 
with BPD constitute a significant predictor of referral to a specialized psychiatric department for severe 
mental disorders after termination of the treatment at a specialized outpatient clinic for personality 
disorders, after adjusting for other co-occurring disorders [31].  
A recent study of 15 to 18-year olds found a positive association between psychotic symptoms as 
assessed by the Youth Self Report and BPD severity, defined as the number of DSM-IV criteria, after 
adjusting for other psychopathology and functional impairment [32]. In another study of 15-25 year olds 
with full-threshold BPD, those who experienced AVH showed higher levels of psychopathology (i.e., self-
harm, paranoid ideation, dissociation, anxiety and stress), compared with those who did not [25]. These 
results add to the adult literature suggesting that patients with both BPD and psychotic symptoms belong 
to a subgroup with a more severe form of BPD.  
 
2.3.  Summary 
Research over the last two decades has shown that AVH occur frequently in individuals with BPD, are not 
exclusively transient but can also be prolonged, are more notable for their similarities with AVH in 
schizophrenia than for any differences, and tend to intensify when the person is under stress in the same 
way that positive symptoms increase with stress in psychotic disorders. Delusions are also common, but 
patients with BPD differ from those with schizophrenia in their lack of negative psychotic symptoms and 
disorganization. In BPD, psychotic symptoms are associated with greater distress, co-occurring 
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psychopathology, suicidal risk, and hospital readmission, suggesting that they should be seen as a marker 
of illness severity. 
 
3. Adolescence and young adulthood is a sensitive time period for the emergence of both BPD and 
psychosis 
Adolescence and young adulthood is the time period when both BPD features [33,34] and psychotic 
symptoms [35] usually emerge for the first time. At this early stage it can be difficult to differentiate 
whether psychotic symptoms are inherent to BPD or indicate an increased risk for the development of a 
psychotic disorder. While the majority of studies have investigated the co-occurrence of psychotic 
symptoms and BPD in adults, there is very limited research examining associations of BPD and 
subthreshold or threshold psychotic disorders. In the following section we will summarize the few 
prospective studies that have examined the association between BPD and subsequent psychosis, and then 
propose a developmental framework for the co-occurrence of BPD and psychotic symptoms in youth that 
might inform treatment and future research. 
 A few studies have investigated the predictive value of BPD assessed at baseline in individuals at 
clinical high risk for psychosis (CHR) for transition to a manifest psychotic disorder [36–39]. BPD neither 
increased nor decreases the risk for transition. In those individuals who made the transition, the presence 
of a baseline BPD diagnosis or BPD features was unrelated to the type of psychotic disorder diagnosis. A 
recent study investigated the psychopathological outcomes of adolescents with BPD using path analysis to 
control for the associations between all outcomes. BPD symptoms assessed at age 11-12 years were 
related to psychotic symptoms at age 12, which were linked to psychotic symptoms at age 18 years, with 
depressive symptoms at 12 years and hypomanic symptoms at 22-23 years. Psychotic disorders were not 
included as outcome variable in this study, as their frequency was too low [40]. Based on these findings, it 
could be cautiously concluded that youth with BPD and psychotic symptoms are at risk of a wide range of 
future psychopathologies, including both non-psychotic and psychotic disorders (i.e., multifinality or 
heterotypic continuity as a developmental pathway).  
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Caspi et al. [41] have proposed that one general underlying dimension, the “p” factor, summarizes an 
individual’s vulnerability to develop any form of psychopathology, and that psychotic symptoms are at the 
p factor’s pinnacle. Any individual with a strong vulnerability for general psychopathology might, if 
severe enough, experience psychotic symptoms, regardless of the presenting diagnosis. Incorporating this 
model into personality pathology, Sharp [34,42] suggests that adolescent BPD symptoms might be 
understood as a manifestation of the confluence of internalizing and externalizing psychopathology, on a 
severity pathway that leads to subsequent major mental disorders, including psychotic disorders. Based on 
these considerations and the research reviewed above, we propose BPD is a severity factor, and so is 
psychosis. If they co-occur, they act synergistically in determining prognosis. Young people having both 
BPD and psychotic symptoms should be considered as having severe psychopathology and being at high 
risk for a wide range of poor outcomes, including the development of another serious mental disorder 
(without being specific to any particular disorder) as well as outcomes beyond the narrow concept of 
diagnosis (e.g., suicidality, severe and persistent functional impairments). 
 
4. Clinical considerations 
The evidence summarized in this review has important clinical implications. First, as psychotic symptoms 
in BPD are not limited to stress-related, transient paranoid ideation, the BPD criteria in the ICD and DSM 
are likely to require revision. The historical narrative that psychotic symptoms in BPD are somehow not 
real, transient, or quasi in nature is a disrespectful myth that is inconsistent with the current evidence 
regarding the subjective experience of patients. Second, clinicians should routinely enquire whether 
patients with BPD experience AVH or other psychotic symptoms. When present, AVH should be 
considered as legitimately as such a report in a patient with another DSM-5 psychotic disorder. Labels 
such as “psuedohallucinations” or “quasi-psychotic” simply add to the stigma already experienced by 
those with BPD and should, thus, be avoided. Third, it is a false dichotomy to consider that such patients 
have either BPD or a psychotic disorder. In fact, they have both. As in depression and bipolar disorder, 
psychotic symptoms are simply a marker of more severe disorder. Fourth, while hallucinations 
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(particularly AVH) and delusions are common among people with BPD, co-occurring negative symptoms 
and disorganized thought are uncommon and might indicate the presence of an even more extensive 
illness. Finally, when planning treatment, clinicians should take into account that individuals with BPD 
and psychotic symptoms are at a greater risk of developing a range of negative outcomes, including 
suicide.  
 
5. Future directions in the study of psychotic symptoms in borderline personality disorder 
The evidence presented here has reignited the debate about the validity of the BPD concept and its 
questionable distinction from the schizophrenia spectrum [43]. Future research should not become bogged 
down in such spurious categorical distinctions. Studies should recognize both the dimensional and 
dynamic nature of psychopathology and evolving phenotypes across the transition from childhood to 
adulthood by adopting a clinical staging approach. Such an approach needs to incorporate the 
measurement of personality pathology [44,45] in order to focus on etiological factors of and treatment 
options for psychotic symptoms in BPD.  
Except for one study investigating sensory gating deficiencies (a candidate mechanism of AVH in 
patients with schizophrenia) in adults with BPD and AVH [46], there are few studies examining neural 
correlates of psychotic symptoms in BPD [47]. In addition, the role of childhood adversity and 
dissociation in the development of psychotic symptoms in BPD needs clarification. While there is robust 
evidence for an indirect link between childhood adversity and both delusions and hallucinations, via 
dissociation, in psychotic disorder [e.g., 48,49], inconsistent findings have been reported in BPD 
[11,12,15,16,18,19,25].  
To date, no randomized controlled trial (RCT) has investigated the efficacy of antipsychotic 
medication or psychological interventions for AVH (or any other positive symptom) in BPD [15], 
measuring AVH as a primary outcome and using standardized measures to assess AVH employed in 
RCTs for psychotic disorders [15,50]. Yet there is evidence that youth with both first-episode psychosis 
and co-occurring BPD have poorer access to standard treatment, including guideline concordant 
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antipsychotic medication prescription [51]. A first RCT on ariprirazole in youth with BPD and AVH in 
currently underway [50]. In addition, there is preliminary evidence suggesting that both negative beliefs 
about voices [20,26] and the self [52] contribute to emotional distress in BPD who experience AVH, and 
could, thus, become the target for psychological therapies, such as cognitive behavioral therapy or 
interventions addressing the self-experience at the narrative level [53,54]. 
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